kalcoral-d 500/200 tablet
popular pharmaceuticals ltd. - calcium (coral calcium) + vitamin d3 - tablet - 500 mg + 200 iu
maxcoral-d tablet
biogen pharmaceuticals ltd. - calcium (coral calcium) + vitamin d3 - tablet - 500 mg + 200 iu
maxcoral-dx tablet
biogen pharmaceuticals ltd. - calcium (coral calcium) + vitamin d3 - tablet - 600 mg + 400 iu
coral cd tablet
rangs pharmaceuticals ltd. - calcium (coral calcium) + vitamin d3 - tablet - 500 mg + 200 iu
bsm coral calcium plus tablet
bio-science marketing sdn. bhd. - coral calcium; vitamin k2; vitamin d3 (cholecalciferol) -
tachisan marine coral calcium & k2 plus softgel
tachisan enterprise (m) sdn. bhd. - coral calcium; vitamin k2; dl-alpha tocopheryl acetate; vitamin d3 (cholecalciferol) -
coral cay mega b
coral cay health pty ltd - biotin,calcium pantothenate,choline bitartrate,cyanocobalamin,folic acid,inositol,magnesium oxide,nicotinamide,pyridoxine hydrochloride,riboflavin,thiamine hydrochloride,zinc sulfate monohydrate -
procoralan
les laboratoires servier - ivabradine hydrochloride - angina pectoris; heart failure - cardiac therapy - symptomatic treatment of chronic stable angina pectoris ivabradine is indicated for the symptomatic treatment of chronic stable angina pectoris in coronary artery disease adults with normal sinus rhythm and heart rate ≥ 70 bpm. ivabradine is indicated :in adults unable to tolerate or with a contraindication to the use of beta-blockersor in combination with beta-blockers in patients inadequately controlled with an optimal beta-blocker dose.treatment of chronic heart failure ivabradine is indicated in chronic heart failure nyha ii to iv class with systolic dysfunction, in patients in sinus rhythm and whose heart rate is ≥ 75 bpm, in combination with standard therapy including beta-blocker therapy or when beta-blocker therapy is contraindicated or not tolerated.
coralan 7.5 mg
medison pharma ltd - ivabradine as hydrochloride - film coated tablets - ivabradine as hydrochloride 7.5 mg - ivabradine - ivabradine - symptomatic treatment of chronic stable angina pectoris in patients with normal sinus rhythm, who have a contra-indication or intolerance for beta-blockers.treatment of chronic heart failureivabradine is indicated in chronic heart failure nyha ii to iv class with systolic dysfunction, in patients in sinus rhythm and whose heart rate is ≥ 75 bpm, in combination with standard therapy including beta-blocker therapy or when beta-blocker therapy is contraindicated or not tolerated.
coralan 5 mg
medison pharma ltd - ivabradine as hydrochloride - film coated tablets - ivabradine as hydrochloride 5 mg - ivabradine - ivabradine - symptomatic treatment of chronic stable angina pectoris in patients with normal sinus rhythm, who have a contra-indication or intolerance for beta-blockers.treatment of chronic heart failureivabradine is indicated in chronic heart failure nyha ii to iv class with systolic dysfunction, in patients in sinus rhythm and whose heart rate is ≥ 75 bpm, in combination with standard therapy including beta-blocker therapy or when beta-blocker therapy is contraindicated or not tolerated.